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Abstract
The objective of this study was to elucidate the toxicity of widely used penetrating cryoprotective agents (CPAs) to
mammalian oocytes. To this end, mouse metaphase II (M II) oocytes were exposed to 1.5 M solutions of dimethylsulfoxide
(DMSO), ethylene glycol (EG), or propanediol (PROH) prepared in phosphate buffered saline (PBS) containing 10% fetal
bovine serum. To address the time- and temperature-dependence of the CPA toxicity, M II oocytes were exposed to the
aforementioned CPAs at room temperature (RT, ,23uC) and 37uC for 15 or 30 minutes. Subsequently, the toxicity of each
CPA was evaluated by examining post-exposure survival, fertilization, embryonic development, chromosomal abnormalities,
and parthenogenetic activation of treated oocytes. Untreated oocytes served as controls. Exposure of MII oocytes to 1.5 M
DMSO or 1.5 M EG at RT for 15 min did not adversely affect any of the evaluated criteria. In contrast, 1.5 M PROH induced a
significant increase in oocyte degeneration (54.2%) and parthenogenetic activation (16%) under same conditions. When the
CPA exposure was performed at 37uC, the toxic effect of PROH further increased, resulting in lower survival (15%) and no
fertilization while the toxicity of DMSO and EG was still insignificant. Nevertheless, it was possible to completely avoid the
toxicity of PROH by decreasing its concentration to 0.75 M and combining it with 0.75 M DMSO to bring the total CPA
concentration to a cryoprotective level. Moreover, combining lower concentrations (i.e., 0.75 M) of PROH and DMSO
significantly improved the cryosurvival of MII oocytes compared to the equivalent concentration of DMSO alone. Taken
together, our results suggest that from the perspective of CPA toxicity, DMSO and EG are safer to use in slow cooling
protocols while a lower concentration of PROH can be combined with another CPA to avoid its toxicity and to improve the
cryosurvival as well.
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Introduction
Successful cryopreservation of human oocytes would facilitate
treatment of female infertility resulting from cancer therapy and
premature ovarian failure, and would avoid many legal and ethical
complications of embryo freezing. Furthermore, successful oocyte
banking may help with delayed child-bearing, conservation of
genetic material of endangered species, and improving livestock
breeding. Although the first successful cryopreservation of mouse
and human oocytes was achieved, respectively, in the 1970s [1,2]
and 1980s [3], reproducing the initial success of human oocyte
cryopreservation has proved to be challenging due to diverse
cryoinjuries/stresses caused by exposure to cryoprotective agents
(CPAs), cooling, and combination thereof. Such injuries include
intracellular ice formation [4], solution effects injury [5], chilling
injury [6], depolymerization/disruption of the oocyte cytoskeleton
and spindle microtubules [7,8], premature exocytosis of cortical
granules and zona hardening [9], parthenogenetic activation
[10,11], and aneuploidy/polyploidy [8,12]. The use of intracyto-
plasmic sperm injection (ICSI) in conjunction with oocyte
cryopreservation has overcome the fertilization failure caused by
zona hardening and has led to a live birth [13]. Subsequently,
encouraging results have been reported using both slow cooling
[14,15] and vitrification techniques [16,17,18]. However, further
research is needed to address other cryoinjuries and to develop
safe, reliable, and efficient cryopreservation protocols.
To survive the cryopreservation process, cells typically require
the presence of CPAs, a class of compounds that specifically act to
maintain the viability of cryopreserved cells [19]. The protective
nature of penetrating CPAs was first discovered through the use of
glycerol in 1949 [20]. Later, dimethylsulfoxide (DMSO) [21] and
other polyols such as 1,2-propanediol (PROH) and 1,2-ethandiol
(also called ethylene glycol, EG) [22,23] were introduced and
successfully used in cryopreservation of many cell types.
Concurrently, CPA toxicity has been recognized as a critical
barrier to further advancement of the field. In fact, the toxicity of
CPAs has been considered as the single most limiting factor to
development of successful cryopreservation protocols for challeng-
ing cells and tissues [24]. This is particularly true for vitrification
protocols that require initial high CPA concentrations to bring
samples into a glassy state without ice formation. Consequently,
CPA toxicity has been studied mostly from the perspective of
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centrations of CPAs used in slow cooling protocols could also be
toxic [10,33,34,35,36,37]. One obvious approach to cope with
CPA toxicity would be the use of less toxic CPAs in
cryopreservation techniques. Thus far, toxicity studies have
yielded inconsistent results with no consensus on the least and
most toxic CPA(s). For instance, PROH [26,32,38,39,40], EG
[28,30,33], and DMSO [29,31] have each been found to be the
least toxic CPA among those tested while each of these CPAs was
also found to be the most toxic in different studies
[28,29,30,31,32,33,40]. These discrepancies might be due to
differences in experimental protocols, cell type, and species. With
the exception of a few [28,32,33], most of the toxicity studies
combined the CPA exposure with different cryopreservation
procedures, further complicating the toxicity outcome. None of
the studies compared the toxicity of three widely used penetrating
CPAs (i.e., DMSO, PROH, and EG) side-by-side from the
perspective of slow cooling protocols. Taken together, the area of
CPA toxicity remains one of considerable uncertainty and is ripe
for re-evaluation, as stated in a recent review [41].
The objective of this study was to systematically compare the
toxicity of the aforementioned three penetrating CPAs (i.e.,
DMSO, PROH, and EG) from the perspective of slow cooling
protocols and to develop a strategy to avoid potential CPA
toxicity. Glycerol was excluded due to its inability to adequately
permeate oocytes. To decouple the effect of a given cryopreser-
vation protocol, mouse oocytes were exposed to each CPA at
different temperatures for different durations of time, without
subjecting them to a freeze-thaw cycle. Thereafter, treated oocytes
were analyzed for survival, fertilization, embryonic development,
as well as for chromosomal abnormalities (ploidy) and partheno-
genetic activation compared to untreated controls. Additional
experiments were undertaken to circumvent CPA toxicity by
combining lower concentrations of CPAs while keeping the total
CPA concentration unchanged.
Materials and Methods
Reagents and Media
All chemicals were purchased from Sigma (St. Louis, MO)
unless otherwise stated. HEPES-buffered Dulbecco’s Modified
Eagle Medium (DMEM)/F-12 mixture (Gibco, Grand Island, NY)
containing 10% fetal bovine serum (FBS) (Gemini Bio-Products,
West Sacramento, CA) was used for all oocyte manipulations
under air. Dulbecco’s Phosphate Buffered Saline (DPBS) (Gibco,
Grand Island, NY) containing 10% of FBS served as a base to
prepare CPA solutions. Oocytes and embryos were cultured in
bicarbonate-buffered Hypermedium [42] containing 4 mg/ml
bovine serum albumin (BSA) (Serologicals Proteins Inc., Kanka-
kee, IL) at 37uC under a humidified atmosphere of 5% CO2 in air.
Dispersion of sperm was performed in a 0.4-ml drop of DMEM.
Prior to use, drops of the Hypermedium and DMEM were
overlaid by embryo-tested mineral oil (Humco, Texarkana, TX)
and equilibrated overnight under a humidified atmosphere of 5%
CO2 in air.
Oocyte Isolation
Metaphase II (M II) oocytes were obtained from 5–8 week-old
B6D2F1 hybrid mice (C57BL/6NCrl X DBA/2NCrl; NCI,
Frederick, MD). This was approved by the Institutional Animal
Care and Use Committee at Georgia Health Science University
(AUP# BR09-11-267). Superovulation was induced by a combi-
nation of 5 IU pregnant mare serum gonadotropin and 2.5 IU
human chorionic gonadotropin (hCG) (PG 600, Intervet, Mill-
sboro, DE) followed by 7.5 IU hCG alone 49 hours later. Both
hormone solutions were given intraperitoneally. To collect M II
oocytes, the oviducts were excised from euthanized mice 14 hours
after hCG injection and oocyte-cumulus masses were released
from the ampulla. To remove cumulus cells, the oocyte-cumulus
masses were exposed to 120 IU/ml of bovine testis hyaluronidase
(Type IV-S) at ambient temperature for 3–4 min. Next, the
oocytes were washed in DMEM/F-12 with 10% FBS twice and
then transferred to Hypermedium for recovery before experimen-
tation. For each experiment, oocytes that were isolated from 3 to 4
females were pooled and then randomly distributed to experi-
mental groups.
Cryoprotectant Exposure Experiments
To elucidate the toxicity of penetrating CPAs, we conducted a
series of comprehensive experiments. The first set of CPA
exposure experiments was designed to compare the toxicity of
three conventional penetrating CPAs (i.e., DMSO, EG, and
PROH) at room temperature (RT, 23uC). To this end, we exposed
M II mouse oocytes to a 1.5 M solution of each CPA in
PBS+10%FBS for 15 minutes, a time period sufficient to load
approximately 1.5 M concentration of each CPA at 23uC. The
CPA concentration and exposure time were selected to make them
comparable to values typically used for slow cooling protocols of
mammalian oocytes. At the end of the exposure period, we
stepwise removed the tested CPA by successively transferring
treated oocytes to decreasing CPA concentrations (i.e., 1.0 M,
0.5 M, and 0.0 M) in PBS+10%FBS with 5-minute intervals at
ambient temperature. After 5-minute holding at the final dilution
step, the oocytes were rinsed in a fresh drop of PBS and then
washed one more time in Hypermedium before being transferred
to fresh culture drops of Hypermedium for a recovery period of
1 hour at 37uC. Subsequently, the toxicity of all three CPAs to M
II oocytes was assayed by examining their effect on post-exposure
survival, fertilization, blastocyst formation, chromosomal abnor-
malities, and parthenogenetic activation. To do so, some of the
oocytes were either inseminated or artificially activated as
described below while others were cultured overnight without
any further manipulation to determine parthenogenetic activation
rates after exposure to each CPA. Oocytes that were not exposed
to sperm but cleaved after overnight culture were considered as
parthenogenetically activated. Untreated M II oocytes that were
maintained in Hypermedium at 37uC served as controls. Another
control group consisted of oocytes that were kept in PBS+10%
FBS at RT (23uC) for ,30 minutes, and then transferred to the
culture medium along with CPA-treated oocytes.
The second set of experiments was carried out to test time- and
temperature-dependence of the CPA toxicity by exposing MII
oocytes to 1.5 M solution of each CPA at 37uC for 0, 15, and
30 minutes. The rationale for performing this set of exposure
experiments at 37uC was two-fold: (i) to probe the temperature-
dependence of the CPA toxicity (23uC vs. 37uC); and (ii) to further
challenge the oocytes based on results of the first set of experiments
at 23uC. After the CPA exposure and recovery at 37uC for 1 hour,
the toxicity of the three CPAs was assessed by evaluating post-
exposure survival, fertilization, blastocyst formation, chromosomal
abnormalities, and parthenogenetic activation with respect to non-
treated controls.
The third set of experiments was aimed to address the dose-
dependence of CPA toxicity. We have not tested higher
concentrations (.1.5 M) of the CPAs based on published results
showing that 2.0 M concentrations of all three CPA have a
significant toxic effect on mouse M II oocytes even after a short
exposure period of 3 minutes at RT [28]. Also, it was not
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PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27604necessary to test lower concentrations of DMSO and EG based on
the results of the first two sets of experiments. Consequently, we
focused our experiments on PROH and tested its toxicity by
exposing mouse oocytes to half (0.75 M) of its typical concentra-
tion at both RT and 37uC. Untreated oocytes kept in
Hypermedium at 37uC served as controls.
In the fourth and final set of experiments, we attempted to
alleviate the CPA toxicity by combining lower concentrations (i.e.,
0.75 M) of PROH and DMSO based on previous results while
keeping the combined total concentration of both CPAs at 1.5 M.
Mouse oocytes were exposed to the combined solution of PROH
and DMSO at both RT and 37uC for 15 minutes, and their post-
exposure survival, fertilization, blastocyst formation, chromosomal
abnormalities, and parthenogenetic activation were examined with
respect to non-treated controls. In addition, we carried out
cryopreservation experiments to test whether combining lower
concentrations (i.e., 0.75 M) of PROH and DMSO provides
adequate cryoprotection. To do so, M II oocytes were cryopre-
served in the presence of 0.75 M PROH+0.75 M DMSO in PBS
containing 10% FBS and their post-thaw survival was compared to
those cryopreserved in the presence of 1.5 M DMSO alone, as
described next.
Oocyte Cryopreservation
M II oocytes were randomly allocated to two groups and loaded
with either 0.75 M PROH+0.75 M DMSO or 1.5 M DMSO at
RT as described above. During the last few minutes of CPA
loading, oocytes were aspirated into 0.25-cc plastic straws (TS
Scientific, Perkasie, PA) and placed in a programmable freezer
(KRYO 10 Series III, Planer, Middlesex, UK) at 0uC and cooled
to 26uC at a rate of 2uC/min. After seeding of extracellular ice
and holding at 26uC for 10 min, the straws were first cooled to
260uC at 0.5uC/min and then 280uCa t5 uC/min where they
were held for 2 min before plunging into liquid nitrogen. Thawing
was done by introducing the straws into the controlled-rate freezer
at 280uC and warming them up to 0uCa t8 uC/min.
Subsequently, the contents of the straws were released into an
empty dish, and then CPAs were diluted by transferring oocytes to
successive lower CPA concentrations (i.e., either 0.50 M
PROH+0.50 M DMSO, 0.25 M PROH+0.25 M DMSO, and
PBS+10% FBS or 1.0 M DMSO, 0.5 M DMSO, and PBS+10%
FBS) at RT with 10-min intervals. Next, oocytes were rinsed in
PBS+10% FBS one more time before transferring to Hyperme-
dium for incubation at 37uC. Post-thaw survival of cryopreserved
oocytes was assessed after .1 h of culture at 37uCb y
morphological criteria that included translucent appearance of
cytoplasm, integrity of the plasma membrane and the zona
pellucida, and the size of the perivitelline space.
In Vitro Fertilization and Embryo Culture
In vitro fertilization (IVF) and culture of inseminated oocytes
were carried out in Hypermedium at 37uC under a humidified
atmosphere of 5% CO2 in air as described elsewhere [43]. Briefly,
sperm were obtained from the cauda epididymides of a mature (4–
6 months old) BDF1 male mice (NCI). The cauda epididymides
were dissected and placed in a large drop (0.4 ml) of pre-
equilibrated DMEM. Sperm were released into the medium by
gently puncturing the epididymides with a hypodermic needle and
were allowed to disperse at 37uC for 15 min. After dispersion, an
appropriate volume of the sperm suspension was added to each
insemination drop containing Hypermedium with BSA supple-
mentation to give a final concentration of 1–2610
6 sperm/ml.
The insemination drops were then incubated for 1–2 h to
capacitate sperm before introducing untreated and treated
oocytes. After 5–6 h of incubation with sperm, all oocytes were
washed twice in Hypermedium and then cultured in fresh drops of
the same medium. Cleavage to the two-cell stage was examined
after overnight culture while development to the blastocyst stage
was evaluated after an additional 4 days of culture. Fertilization
and blastocyst formation rates were calculated based on the
number of surviving oocytes and two-cell embryos, respectively.
Artificial Activation of M II Oocytes and Chromosomal
Analysis
Since depolymerization/disruption of meiotic spindle microtu-
bules and microfilaments by penetrating CPAs may result in
dispersion and improper segregation of chromosomes after
activation of oocytes by sperm, it is important to address the
consequences of the cytoskeletal toxicity of penetrating CPAs. To
this end, we decided to analyze chromosomal abnormalities after
artificial activation because this approach eliminates any contri-
bution of sperm-originated chromosomal abnormalities. After a
post-exposure recovery period of 1 h, both CPA- exposed and
untreated control oocytes were artificially activated by incubating
them in a modified calcium- and magnesium-free Hypermedium
containing 10 mM SrCl2 at 37uC for 5–6 h. At the end of the
incubation period, all oocytes were washed three times in regular
Hypermedium and microscopically examined for evidence of
activation. Oocytes that displayed the 2
nd polar body and a
pronucleus were considered as activated and further cultured for
chromosomal analysis as described below.
Activated oocytes were cultured overnight in Hypermedium
supplemented with 1 mg/mL colcemid (Gibco, Grand Island, NY)
to arrest cell division at metaphase. Thereafter, chromosome
spreads were prepared using a modified gradual fixation/air
drying method [44] as follows: First, oocytes were exposed to
acidic Tyrode’s solution to remove zona pellucida, and then
transferred to a hypotonic citrate solution (0.9% sodium
citrate:30% FBS; 3:1) for 30 min. Next, a single oocyte was
transferred to a small drop of the hypotonic solution on a grease-
free slide; fixative I, consisting of methanol (Fisher chemicals),
glacial acetic acid (Across organic, New Jersey), and distilled water
(5:1:4), was gradually added to the drop. After 5 minutes, the fixed
oocyte was transferred to a new grease-free slide in a minimum
volume of fixative I. Following mounting, the oocyte was covered
with a gentle flow of fixative II (methanol:glacial acetic acid, 3:1),
and the slide was immediately placed in a Coplin jar containing
fixative II for 10 min. Afterwards, the slide was dipped into
fixative III (methanol: glacial acetic acid:distilled water, 3:3:1) for
1 min and then dried by blowing warm air. Finally, chromosome
spreads were stained with 5% Giemsa (EMD Chemicals, La Jolla,
CA) for 15 min to assess chromosomal normality.
Statistical Analysis
Experiments in each series were repeated at least three times
using at least 10 oocytes per experimental group in each replicate.
The total number of oocytes (n) used in each experimental group
was shown in figures. The data on post-exposure survival,
fertilization, and blastocyst rates were analyzed by ANOVA with
Tukey’s Multiple Comparison Test using GraphPad Prism
(GraphPad Software, Inc., San Diego, CA). Before ANOVA,
arcsine transformation was performed on proportional data. The
data on parthenogenetic activation, ploidy, and post-thaw survival
were analyzed by Fisher’s Exact Test using GraphPad Prism.
Differences between the groups were considered statistically
significant when the p-value was less than 0.05. Data reported
are means of survival, fertilization, development, and partheno-
genetic activation rates with error bars representing standard error
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number of euploid eggs pooled from three replicates. Therefore,
the ploidy rates do not have error bars.
Results
Toxicity of CPAs at Room Temperature
This set of CPA exposure experiments was designed to compare
the toxicity of penetrating CPAs from the perspective of slow
cooling protocols. To this end, M II oocytes were exposed to a
1.5 M solution of each CPA for 15 minutes and subsequently
analyzed along with controls. Some control oocytes were held at
23uC without exposure to any CPA to decouple the effect of
cooling to RT. A total of 555 oocytes were used to elucidate the
effect of the three CPAs on post-exposure survival, fertilization and
development. The results are summarized in Fig. 1. Similar
proportions of control oocytes kept at 37uC or exposed to RT were
fertilized (95.4% and 100%, respectively) and developed to the
blastocyst stage (86.5% and 86.9%, respectively), suggesting that
keeping mouse oocytes at RT up to 30 min does not have a
negative impact on fertilization and embryonic development.
Similarly, exposure to 1.5 M DMSO or 1.5 M EG did not
adversely affect morphological survival of the oocytes (100% and
99%, respectively) compared to controls at 37uC (100%) and RT
(100%). In contrast, less than half (45.8%) of the oocytes survived
the exposure to 1.5 M PROH at RT for 15 min, indicating the
toxic effect of PROH. This survival rate after exposure to 1.5 M
PROH was significantly lower than that for all the other groups.
Among the surviving oocytes, the fertilization and embryonic
development rates were similar in DMSO- (98.8% and 84.8%,
respectively), EG- (94.1% and 84.0%, respectively), and PROH-
exposure (88.0% and 87.3%, respectively) groups, and were
comparable to controls.
To further probe the toxicity of the three penetrating CPAs, we
also examined chromosomal abnormalities and parthenogenetic
activation after CPA exposure using a total of 143 and 173
oocytes, respectively. Similar artificial activation rates were
obtained in control (94%) and CPA-exposure (92–97%) groups.
As shown in Fig. 1B, none of the three CPAs induced a significant
increase in chromosomal abnormalities compared to controls. The
euploidy rates remained high and were 92%, 96%, 100%, and
95% for DMSO, EG, PROH, and controls, respectively.
However, the rate of parthenogenetic activation was significantly
higher (15.3%) after exposure to 1.5 M PROH compared to that
of the two other CPAs and controls (0% for all) as shown in
Fig. 1C.
Time- and Temperature-Dependence of CPA Toxicity
To elucidate time- and temperature-dependence of CPA
toxicity, MII oocytes were first exposed to a 1.5 M solution of
each CPA at 37uC for 0, 15, and 30 minutes, and then analyzed
for their post-exposure survival, fertilization, and blastocyst rates,
as well as for their chromosomal abnormalities, and parthenoge-
netic activation with respect to non-treated controls. A total of 750
oocytes were used for this set of experiments. The results are
summarized in Fig. 2. Raising the exposure temperature from RT
to 37uC further increased the toxic effect of PROH, leading to
degeneration of the vast majority of oocytes (85.0% after
Figure 1. Toxicity of penetrating CPAs at room temperature. Ovulated mouse oocytes were exposed to a 1.5 M solution of each CPA at RT
(,23uC) for 15 minutes and evaluated for their (A) post-exposure survival, fertilization, and embryonic development, as well as for their (B) ploidy and
(C) parthenogenetic activation. Data shown are mean6SEM except for the ploidy rates, which represent percentage of total number of euploid eggs.
The total number of oocytes (n) used in each group was also shown. * denotes significant differences in survival and parthenogenetic activation
(p,0.05).
doi:10.1371/journal.pone.0027604.g001
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the surviving oocytes failed to fertilize, resulting in no embryonic
development. In contrast, the toxicity of DMSO and EG at 37uC
still remained insignificant after 15 minutes of exposure to their
1.5 M concentrations, with survival (97.3% and 90.2%, respec-
tively), fertilization (90.0% and 95.6%, respectively), and blastocyst
rates (96.7% and 97.6%, respectively) comparable to those of
controls (100%, 95.3%, and 93.7%, respectively). Also, prolonging
the exposure time to 30 minutes did not increase the toxic effect of
DMSO and EG in terms of survival (91.7% and 100.0%,
respectively), fertilization (86.3% and 94.0%, respectively), and
embryonic development (94.3% and 92.7%, respectively). Simi-
larly, exposure to DMSO and EG at 37uC for 30 minutes did not
induce a significant increase in chromosomal abnormalities (25%
and 14%, respectively) and parthenogenetic activation (10% and
2.3%, respectively) with respect to controls (5% and 0%,
respectively).
Dose-Dependence of CPA Toxicity
Based on the insignificant toxicity of DMSO and EG at their
1.5 M concentration (see the results above) and the substantial
toxicity of higher concentrations ($2 M) of all three CPAs even
after a short exposure (3 min) at RT [28], it was not necessary to
test high concentrations of none of the CPAs and lower
concentrations of DMSO and EG. Therefore, we focused our
experiments on PROH to see whether there was a dose-dependent
decrease in its toxicity. To this end, we tested half (0.75 M) of its
typical concentration at both RT and 37uC with respect to
untreated controls using a total of 263 oocytes. As shown in Fig. 3,
upon exposure to half of its typical slow cooling concentration, the
toxicity of PROH completely disappeared, resulting in post-
exposure survival (100%), fertilization (90,3%), and embryonic
development (96.3%) rates similar to those of controls (100%,
97.2%, and 85.8%, respectively). Raising the exposure tempera-
ture to 37uC also did not induce any significant toxicity in terms of
post-exposure survival (100%), fertilization (87.7%), and embry-
onic development (87.7%) compared to untreated controls.
Furthermore, no parthenogenetic activation was observed after
exposure to 0.75 M PROH at 37uC for 15 minutes, suggesting a
strong dose-dependence of PROH toxicity. Chromosomal abnor-
malities were not tested because even higher concentrations of
PROH (1.5 M) did not caused any toxicity.
Avoidance of CPA Toxicity and Comparison of Post-Thaw
Survival
PROH is a preferred CPA [45,46] as a result of its good glass-
forming properties and high membrane permeation that results in
less volumetric perturbations. Based on the encouraging results
with 0.75 M PROH, we asked the question whether PROH can
safely be used in slow cooling protocols by combining its lower
concentration (0.75 M) with another penetrating CPA (e.g.,
0.75 M DMSO) to bring the combined total CPA concentration
to a cryoprotective level (i.e., 1.5 M) without increasing the overall
CPA toxicity. To this end, mouse oocytes were exposed to a
combined solution of 0.75 M PROH and 0.75 M DMSO at both
RT and 37uC for 15 minutes, and their post-exposure survival,
fertilization, and embryonic development rates were examined
with respect to non-treated controls. A total of 168 oocytes were
used for this set of experiments. As shown in Fig. 4A, exposure of
M II oocytes to the combined 1.5 M concentration of PROH and
DMSO at RT did not adversely affect their post-exposure survival
(98.9%), fertilization (92.7%), and embryonic development
Figure 2. Time- and temperature-dependence of CPA toxicity. Ovulated mouse oocytes were exposed to a 1.5 M solution of each CPA at
37uC for 0, 15, and 30 minutes and evaluated for their (A) post-exposure survival, (B) fertilization, (C) embryonic development, (D) parthenogenetic
activation, and (E) ploidy. Data shown are mean6SEM except for the ploidy rates, which represent percentage of total number of euploid eggs. The
total number of oocytes (n) used in each group was also shown. The differences between the control, DMSO and EG groups were not significant
while only a few oocytes survived exposure to 1.5 M PROH at 37uC. Therefore, parthenogenetic activation and ploidy were not evaluated in the PROH
group. N/A: not applicable.
doi:10.1371/journal.pone.0027604.g002
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respectively). When the exposure temperature was raised to
37uC, the survival (95.2%), fertilization (88.9%), and embryonic
development (78.3%) rates were still comparable to controls,
suggesting that a combination of two CPAs can be helpful to
increase the total CPA concentration without increasing CPA
toxicity.
Furthermore, we also tested the cryoprotective effect of the
combined 0.75-M concentrations of PROH and DMSO with
respect to a commonly used concentration (i.e., 1.5 M) of DMSO
alone by subjecting a total of 115 M II oocytes to freezing and
thawing in the presence of the respective CPA solutions. As shown
in Fig. 4B, combining lower concentrations (i.e., 0.75 M) of
PROH and DMSO not only avoids CPA toxicity but also
significantly improves the cryosurvival rate (85.2%) in comparison
to that (50.8%) of the widely used equivalent concentration (i.e.,
1.5 M) of DMSO alone.
Discussion
The toxicity of CPAs has been a limiting step for the use of high
CPA concentrations, and thus for improvement of cryopreserva-
tion protocols. One strategy to deal with this issue is to employ less
toxic but reasonably efficient CPAs. In the present study, we
compared the toxicity of three commonly used penetrating CPAs
(i.e., DMSO, EG, and PROH) to find a less toxic CPA for
cryopreservation of mammalian oocytes. Our results involving
survival, fertilization, embryonic development, as well as chromo-
somal abnormalities and parthenogenetic activation of mouse
oocytes after exposure to each CPA at different temperatures for
different durations show that DMSO and EG at their moderate
concentrations (i.e., 1.5 M) are safer to use for oocyte cryopres-
ervation than 1.5 M PROH. Nevertheless, the toxicity of PROH
could also be avoided by combining its lower concentration (i.e.,
0.75 M) with 0.75 M DMSO while keeping the total CPA
Figure 3. Dose-dependence of the toxicity of PROH. Ovulated mouse oocytes were exposed to a 0.75 M solution of PROH at both RT and 37uC
for 15 minutes and then evaluated for their (A) post-exposure survival, fertilization, and embryonic development, as well as for their (B)
parthenogenetic activation rate. Data shown are mean6SEM. The total number of oocytes (n) used in each group was also shown. There was no
significant difference between the groups (p.0.05).
doi:10.1371/journal.pone.0027604.g003
Figure 4. Avoidance of CPA toxicity and improvement of the cryosurvival. (A) Post-exposure survival, fertilization, and embryonic
development. PROH and DMSO were combined using half (i.e., 0.75 M) of their typical concentrations to bring the total CPA concentration to a
cryoprotective level without a significant toxic effect. Subsequently, ovulated mouse oocytes were exposed to a 1.5-M mixture of PROH and DMSO at
both RT and 37uC for 15 minutes, and then were evaluated for their post-exposure survival, fertilization, and embryonic development rates. Data
shown are mean6SEM. The total number of oocytes (n) used in each group was also shown. There was no significant difference between the groups
(p.0.05). (B) Post-thaw survival rates. Ovulated mouse oocytes were loaded with either 0.75 M PROH+0.75 M DMSO or 1.5 M DMSO at RT for
15 minutes, and then subjected a freeze-thaw cycle to evaluate the cryoprotection of the combined 0.75-M concentrations of PROH and DMSO with
respect to a commonly used concentration of DMSO alone. Data shown are mean6SEM. The total number of oocytes (n) used in each group was also
shown. * denotes significant difference in the cryosurvival (p,0.001).
doi:10.1371/journal.pone.0027604.g004
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could also improve the cryosurvival, as demonstrated by our
cryopreservation experiments in the present study.
Although there is no consensus on less or more toxic penetrating
CPAs, published studies generally agree that the toxicity of
penetrating CPAs increases with increased CPA concentration,
higher exposure temperature, and longer exposure time. In the
present study, extending the CPA exposure duration from
15 minutes to 30 minutes and raising the exposure temperature
from 23uCt o3 7 uC did not significantly increase the toxic effect of
1.5 M DMSO and 1.5 M EG on viability, fertilization, embryonic
development, parthenogenetic activation, and chromosomal
normality of mouse oocytes while the toxicity of 1.5 M PROH
was significantly increased, as indicated by degeneration of the
vast majority of PROH-exposed oocytes. These results suggest that
the time- and temperature-dependence of CPA toxicity may
become less pronounced depending on CPA type and concentra-
tion, although our findings do not exclude other toxic effects such
as changes in the oocyte proteome [37]. Overall, our results are
assuring from the perspective of slow cooling protocols, which
typically use CPA concentrations around 1.5 M. However, higher
concentrations of these CPAs induce a significant adverse effect
even within 3 minutes of exposure at RT [28]. Therefore,
vitrification protocols involving high concentrations of CPAs
require a great deal of attention to the timing of CPA exposure
and handling of oocytes.
Earlier studies showed that cooling and exposure to CPAs can
independently induce depolymerization/disruption of the oocyte
cytoskeleton such as microfilaments and meiotic spindle microtu-
bules, potentially leading to dispersion and improper segregation
of chromosomes, failure in polar body formation, and thus
chromosomal abnormalities [47,48,49]. In fact, increased chro-
mosomal abnormalities have been reported after oocyte cryopres-
ervation [12,50,51]. In the present study, no significant increase in
chromosomal abnormalities after CPA exposure suggests that
mouse oocytes were able to recover from CPA-induced damage to
the oocyte cytoskeleton and spindle microtubules. This is
encouraging from the safety perspective although combining the
CPA exposure with cooling/freezing stresses may complicate
things. Also, oocytes from some species seem to have less
competence to restore a damaged spindle [48,52]. Therefore,
additional measures might be useful to protect the meiotic spindle
in such oocytes with limited recovery competence.
Parthenogenetic activation of ovulated oocytes may occur as
result of a number of chemical and physical stimuli, such as
exposure to ethanol [53], Ca
2+ ionophore [54], Sr
2+ [55],
hyaluroidase [55], electric pulse [55], and cooling [55]. It has
also been shown that exposure of mouse M II oocytes to 1.5 M
PROH significantly increases the parthenogenetic activation rate
[10,11]. The results of the present study are consistent with
previous findings. In contrast, no significant increase in the
parthenogenetic activation rate was observed after exposure of
rabbit oocytes to 1.5 M PROH at RT for 30 minutes, suggesting
interspecies differences [49]. Human oocytes also seem to be
somewhat resistant to parthenogenetic activation. Exposure to
1.5 M PROH alone was not sufficient to significantly induce
parthenogenetic activation while a combination of PROH
exposure with a freeze-thaw cycle significantly increased the
number of parthenogenetically activated human oocytes [56].
Together these findings suggest that the extent of CPA toxicity
may vary depending on species. It has been suggested that the
ability of certain compounds such as ethanol and PROH to
artificially activate M II oocytes might be due to the presence of –
OH groups in their structure [10,11]. However, EG, which is
chemically closely related to PROH and also contains two –OH
groups, did not cause parthenogenetic activation in the present
study, suggesting that the presence of –OH groups alone is not
sufficient to induce a significant increase in parthenogenetic
activation.
Despite several published studies on CPA toxicity, its mecha-
nism of action still remains poorly understood. Hydrophobic
interactions between CPAs and proteins [57], and the extent of
hydrogen binding between CPAs and water molecules [27] have
been proposed to explain CPA toxicity. It has also been shown that
CPAs change the intracellular pH [58], cause intracellular Ca
2+
release [59], and induce formaldehyde formation in cryopreser-
vation medium [60]. Further, it has been questioned whether CPA
toxicity is related to osmotic stresses that occur during addition
and removal of CPAs. Although such osmotic stresses can lead to
cytotoxicity [28], experimental evidence suggests that CPAs clearly
induce chemical toxicity [28,61]. Among the tested CPAs, PROH
permeates into mouse oocytes faster than DMSO and EG, and
thus causes less osmotic stresses [62]. Yet, only PROH showed a
significant toxic effect in the present study. Therefore, it is unlikely
that the toxicity of PROH observed here is due to osmotic stresses.
This notion is also supported by an earlier study showing that
stepwise addition and removal of 1.5 M PROH does not reduce its
toxic effect in terms of oocyte degeneration and parthenogenetic
activation [10].
In the present study, we assessed the fertilization rate of control
and CPA-exposed oocytes based on their cleavage to the two-cell
stage. On the other hand, our experiments on parthenogenetic
activation showed that exposure of M II oocytes to 1.5 M PROH
at RT and 1.5-M concentrations of DMSO and EG at 37uC can
induce parthenogenetic activation up to 15%, 10%, and 3%,
respectively. Hence, it is possible that a small proportion of the
two-cell embryos might have been parthenogenetically activated,
which should be taken into account when interpreting these
particular fertilization results. It is also important to note that in
terms of blastocyst quality, we have not observed any significant
morphological difference between the control and CPA exposure
groups. However, long-term effects of CPAs beyond the blastocyst
stage require further comprehensive studies.
In conclusion, DMSO and EG are safer than PROH in terms of
minimization of CPA toxicity in slow cooling protocols. However,
PROH can also be used without significant toxicity by combining
its lower concentration (0.75 M) with another penetrating CPA to
bring the total CPA concentration to a cryoprotective level (i.e.,
1.5 M). Considering the different protective actions of each CPA
[63,64], this approach may also be helpful to improve the overall
cryoprotection, as shown in the present study.
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